D.A. Davidson & CO. acquired a new stake in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 50,112 shares of the company’s stock, valued at approximately $1,392,000. D.A. Davidson & CO. owned 0.11% of ARK Genomic Revolution ETF as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Private Wealth Asset Management LLC grew its holdings in ARK Genomic Revolution ETF by 70.0% in the 2nd quarter. Private Wealth Asset Management LLC now owns 1,275 shares of the company’s stock valued at $31,000 after buying an additional 525 shares during the period. Atlantic Union Bankshares Corp acquired a new stake in shares of ARK Genomic Revolution ETF in the second quarter worth approximately $34,000. Strategic Wealth Investment Group LLC purchased a new stake in ARK Genomic Revolution ETF in the second quarter valued at approximately $38,000. FWL Investment Management LLC grew its holdings in ARK Genomic Revolution ETF by 750.8% in the second quarter. FWL Investment Management LLC now owns 2,765 shares of the company’s stock valued at $67,000 after purchasing an additional 2,440 shares during the period. Finally, Total Investment Management Inc. acquired a new position in ARK Genomic Revolution ETF during the second quarter worth approximately $70,000.
ARK Genomic Revolution ETF Stock Up 29.3%
BATS:ARKG opened at $30.54 on Friday. The firm’s 50 day moving average is $29.66 and its two-hundred day moving average is $27.69. ARK Genomic Revolution ETF has a fifty-two week low of $17.51 and a fifty-two week high of $31.16.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Read More
- Five stocks we like better than ARK Genomic Revolution ETF
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
